Evolent Health Inc reports results for the quarter ended June 30 - Earnings Summary

Evolent Health

08/08/2025 04:53

Evolent Health Inc EVH.N reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 30 cents.  The mean expectation of fourteen analysts for the quarter was for earnings of 8 cents per share. Wall Street expected results to range from 1 cents to 15 cents per share.

Revenue fell 31.3% to $444.33 million from a year ago; analysts expected $459.42 million.

Evolent Health Inc's reported EPS for the quarter was a loss of 44 cents​.

The company reported a quarterly loss of $51.09 million.

Evolent Health Inc shares had fallen by 16.4% this quarter and lost 16.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 26.1% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Evolent Health Inc is $16.00, about 39.4% above its last closing price of $9.69

This summary was machine generated from LSEG data August 8 at 03:53 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.08
-0.10
Missed
Mar. 31 2025
0.10
0.06
Missed
Dec. 31 2024
0.01
-0.02
Missed
Sep. 30 2024
0.34
0.04
Missed